BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4428037
Number of visits today
295
Number of downloads
4063591
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Verhulst E, Garnier D, De Meester I, Bauvois B. Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go? Cancers (Basel) 2022;14:624. [PMID: 35158891 DOI: 10.3390/cancers14030624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Wang J, Lan T, Zhang L, Yan Z, Zhang N, Xu Y, Tao Q. Role and mechanism of fibroblast-activated protein-α expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1135384] [Reference Citation Analysis]
2 Peng S, Yuan X, Li H, Wei Y, Zhou B, Ding G, Bai J. Recent progress in nanocarrier-based drug delivery systems for antitumour metastasis. Eur J Med Chem 2023;252:115259. [PMID: 36934485 DOI: 10.1016/j.ejmech.2023.115259] [Reference Citation Analysis]
3 Tannoury M, Garnier D, Susin SA, Bauvois B. Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next? Cancers (Basel) 2022;14. [PMID: 36551511 DOI: 10.3390/cancers14246026] [Reference Citation Analysis]
4 Wang K, Xuan Z, Liu X, Zheng M, Yang C, Wang H. Immunomodulatory role of metalloproteinase ADAM17 in tumor development. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1059376] [Reference Citation Analysis]
5 Jovanović M, Stanković T, Stojković Burić S, Banković J, Dinić J, Ljujić M, Pešić M, Dragoj M. Decreased TSPAN14 Expression Contributes to NSCLC Progression. Life 2022;12:1291. [DOI: 10.3390/life12091291] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345